Akari Therapeutics PLC (AKTX)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Apr 19, 16:00
1.18
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Market Cap: 9.350M for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 9.588M |
| April 17, 2024 | 8.884M |
| April 16, 2024 | 9.156M |
| April 15, 2024 | 9.508M |
| April 12, 2024 | 9.588M |
| April 11, 2024 | 8.716M |
| April 10, 2024 | 10.30M |
| April 09, 2024 | 10.42M |
| April 08, 2024 | 11.09M |
| April 05, 2024 | 11.17M |
| April 04, 2024 | 11.41M |
| April 03, 2024 | 12.28M |
| April 02, 2024 | 11.96M |
| April 01, 2024 | 11.96M |
| March 28, 2024 | 12.34M |
| March 27, 2024 | 12.31M |
| March 26, 2024 | 12.47M |
| March 25, 2024 | 12.57M |
| March 22, 2024 | 11.98M |
| March 21, 2024 | 12.11M |
| March 20, 2024 | 12.57M |
| March 19, 2024 | 12.84M |
| March 18, 2024 | 13.23M |
| March 15, 2024 | 13.04M |
| March 14, 2024 | 13.50M |
| Date | Value |
|---|---|
| March 13, 2024 | 14.23M |
| March 12, 2024 | 14.16M |
| March 11, 2024 | 14.23M |
| March 08, 2024 | 14.16M |
| March 07, 2024 | 14.69M |
| March 06, 2024 | 14.56M |
| March 05, 2024 | 14.96M |
| March 04, 2024 | 14.89M |
| March 01, 2024 | 15.09M |
| February 29, 2024 | 15.55M |
| February 28, 2024 | 14.69M |
| February 27, 2024 | 15.15M |
| February 26, 2024 | 15.69M |
| February 23, 2024 | 15.48M |
| February 22, 2024 | 14.82M |
| February 21, 2024 | 15.35M |
| February 20, 2024 | 15.82M |
| February 16, 2024 | 14.82M |
| February 15, 2024 | 15.75M |
| February 14, 2024 | 15.88M |
| February 13, 2024 | 15.88M |
| February 12, 2024 | 15.88M |
| February 09, 2024 | 15.88M |
| February 08, 2024 | 16.21M |
| February 07, 2024 | 17.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.716M
Minimum
Apr 11 2024
149.28M
Maximum
Feb 19 2021
50.73M
Average
49.22M
Median
Jul 19 2022
Market Cap Benchmarks
| DBV Technologies SA | 132.81M |
| Adaptimmune Therapeutics PLC | 239.54M |
| Biodexa Pharmaceuticals Plc | 3.230M |
| NuCana PLC | 8.014M |
| Genfit SA | 179.00M |
Market Cap Related Metrics
| Price | 1.18 |
| Earnings Yield | -173.3% |